A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
一项包含95个基因的特征分析能够对ER阳性、HER2阴性、淋巴结阴性乳腺癌的侵袭性疾病复发风险进行分层,其复发评分与包含21个基因的特征分析结果处于中间水平。
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06276-7
Fujii, Takeo; Masuda, Hiroko; Cheng, Yee Chung; Yang, Fei; Sahin, Aysegul A; Naoi, Yasuto; Matsunaga, Yuki; Raghavendra, Akshara; Sinha, Arup Kumar; Fernandez, Jose Rodrigo Espinosa; James, Anjali; Yamagishi, Keisuke; Matsushima, Tomoko; Schuetz, Robert; Tripathy, Debu; Tada, Sachiyo; Jackson, Rubie S; Noguchi, Shinzaburo; Nakamura, Seigo; Acoba, Jared D; Ueno, Naoto T